Suchergebnisse - "Neutralization assay"

PubPharm (32)

1

Development of a proficiency testing program for HPV serology assays used to evaluate antibody responses in vaccine trials

enthalten in: Journal of immunological methods | 2023

von Miller, C. | Kemp, T. | Pinto, L.

2

Diagnostic TR-FRET assays for detection of antibodies in patient samples

enthalten in: Cell reports methods | 2023

von Yue, H. | Nowak, R. | Overwijn, D. | +20

UpdateOf: medRxiv. 2020 Sep 03;:. - PMID 32909004

3

Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron

enthalten in: Viruses | 2023

von Hao, L. | Hsiang, T. | Dalmat, R. | +22

UpdateOf: medRxiv. 2022 Aug 16;:. - PMID 36032965

4

Serum Neutralizing Antibody Titers 12 Months After Coronavirus Disease 2019 Messenger RNA Vaccination : Correlation to Clinical Variables in an Adult, US Population

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Zhao, M. | Slotkin, R. | Sheth, A. | +13

UpdateOf: medRxiv. 2022 May 04;:. - PMID 35411347

5

Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19

enthalten in: Journal of clinical immunology | 2022

von Eto, S. | Nukui, Y. | Tsumura, M. | +27

UpdateOf: Res Sq. 2022 Mar 11;:. - PMID 35291303

6

Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2

enthalten in: Viruses | 2022

von Farrell, A. | Dadonaite, B. | Greaney, A. | +9

UpdateOf: bioRxiv. 2022 Aug 30;:. - PMID 36093349

7

Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting : 2 randomized clinical trials

enthalten in: Vaccine | 2022

von Sadoff, J. | Le Gars, M. | Brandenburg, B. | +16

8

A Single-Round Infection Fluorescent SARS-CoV-2 Neutralization Test for COVID-19 Serological Testing at a Biosafety Level-2 Laboratory

enthalten in: Viruses | 2022

von Zou, J. | Xia, H. | Shi, P. | +2

9

Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series and Additional Dose Vaccine in Patients With Predominant Antibody Deficiency

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Barmettler, S. | DiGiacomo, D. | Yang, N. | +20

10

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

enthalten in: Cell reports. Medicine | 2022

von Edara, V. | Manning, K. | Ellis, M. | +25

UpdateOf: bioRxiv. 2021 Dec 22;:. - PMID 34981056